水晶光電(002273.SZ):終止2019年度非公開發行A股事項
格隆匯 11 月 6日丨水晶光電(002273.SZ)公佈,鑑於資本市場環境及監管政策發生變化,結合公司實際情況及發展規劃等諸多因素,為能更好地開展後續公司戰略部署,進而促使業務更優更快進一步發展,經與中介機構溝通並審慎論證,決定終止2019年度非公開發行A股股票事項。
公司於2020年11月5日召開的第五屆董事會第二十九次會議和第五屆監事會第二十一次會議,審議通過了《關於終止2019年度非公開發行A股股票事項的議案》。公司獨立董事就該事項出具獨立意見,鑑於該次非公開發行相關事宜尚未提交公司股東大會審議,同意公司終止非公開發行A股股票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.